Ads
related to: remdesivir drug- Prescribing Information
Find Prescribing Info & Other
Resources on the HCP Site.
- Register for Updates
Register Here to Get the Latest
Updates for VEKLURY®.
- Prescribing Information
Search results
New Oral COVID-19 Antiviral Might Be Better Than Pfizer's Paxlovid With Faster Recovery, Fewer Side...
Benzinga via Yahoo Finance· 1 year agoA study in China shows that a remdesivir analog, dubbed VV116, is as effective as Pfizer Inc's...
Fewer Black Vets Got Advanced COVID Treatments at VA Hospitals During Pandemic, Study Finds
Military.com via Yahoo News· 2 years agoWhite veterans received advanced therapies for COVID-19 at higher rates than Black veterans in...
Humanigen (HGEN) Plunges as COVID Study Fails to Meet Goal
Zacks via Yahoo Finance· 2 years agoThe NIAID's ACTIV-5/BET-B study evaluating Humanigen's (HGEN) lenzilumab plus remdesivir in...
A One-Shot COVID-19 Treatment Shows Promise
Time via Yahoo News· 1 year agoCredit - Yiu Yu Hoi—Getty Images The current medicine chest for treating COVID-19 is fairly sparse. Only one drug—remdesivir—is approved by the U.S. Food...
These Are the 2 Most Common Symptoms of the New FLiRT COVID Variant Doctors Are Seeing Right Now
Parade via Yahoo News· 12 hours agoFemale patient wearing mask over mouth takes a PCR test for COVID-19 It's been over four years since...
Faulty pulse oximeter readings delayed life-saving treatments for Black COVID-19 patients, research...
INSIDER via Yahoo News· 2 years agoBlack patients waited one hour longer for access to COVID-19 treatments due to a medical device that...
Humanigen's Lenzilumab Disappoints In NIH-Backed COVID-19 Study
Benzinga via Yahoo Finance· 2 years agoHumanigen Inc (NASDAQ: HGEN) has been informed of preliminary topline results from the ACTIV-5/BET-B...
European Commission Signs COVID-19 Drug Procurement Deal With Gilead
Benzinga via Yahoo Finance· 2 years agoGilead Sciences Inc (NASDAQ: GILD) and the European Commission signed a joint procurement agreement...
Buy this Medical Sector Pioneer Stock
Zacks via Yahoo Finance· 1 year agoGilead Sciences GILD shares have continued to rise after beating on both its top and bottom lines in October. GILD stock is up roughly 20% since its Q3...
Gilead (GILD) Q3 Earnings & Sales Top, Guidance Raised
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD reported better-than-expected third-quarter results, driven by continued...
Ads
related to: remdesivir drug